(Q36263693)

13 August 2017

1 reference

title

Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent? (English)

1 reference

13 August 2017

1 reference

Nabil El-Sherif

1

1 reference

13 August 2017

Gioia Turitto

series ordinal

2

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Pacing and Clinical Electrophysiology

13 August 2017

published in

1 reference

13 August 2017

volume

28

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

985-990

1 reference

Pharmacology of carvedilol

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Antiarrhythmic drug carvedilol inhibits HERG potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Down-regulation of sodium current in chronic heart failure: effect of long-term therapy with carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Molecular mechanisms of remodeling in human atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Effect of carvedilol on atrioventricular conduction in the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

β-Blockers are effective in congestive heart failure patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Role of carvedilol in atrial fibrillation: insights from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Comparative effects of carvedilol and amiodarone on conversion and recurrence rates of persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Three decades of clinical trials with beta-blockers: the contribution of the CAPRICORN trial and the effect of carvedilol on serious arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

QT dispersion and sudden unexpected death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2005.00200.X

10.1111/J.1540-8159.2005.00200.X

21 January 2018

Identifiers

DOI

1 reference

release_mg4ukglwkjex5eqwh5a3giz4ma

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mg4ukglwkjex5eqwh5a3giz4ma

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference